These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23276794)

  • 1. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
    Sehrawat A; Kim SH; Vogt A; Singh SV
    Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
    Sehrawat A; Singh SV
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1107-17. PubMed ID: 21464039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzyl isothiocyanate causes FoxO1-mediated autophagic death in human breast cancer cells.
    Xiao D; Bommareddy A; Kim SH; Sehrawat A; Hahm ER; Singh SV
    PLoS One; 2012; 7(3):e32597. PubMed ID: 22457718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.
    Kim SH; Sehrawat A; Singh SV
    Cancer Prev Res (Phila); 2013 Aug; 6(8):782-90. PubMed ID: 23661606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells.
    Kim EJ; Eom SJ; Hong JE; Lee JY; Choi MS; Park JH
    Mol Cell Biochem; 2012 Jan; 359(1-2):431-40. PubMed ID: 21892609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
    Kim SH; Sehrawat A; Singh SV
    Breast Cancer Res Treat; 2012 Aug; 134(3):1067-79. PubMed ID: 22476855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
    Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
    Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression.
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2010 Jun; 3(6):718-26. PubMed ID: 20484174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells.
    Roy R; Hahm ER; White AG; Anderson CJ; Singh SV
    Mol Carcinog; 2019 Jun; 58(6):996-1007. PubMed ID: 30720225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling.
    Jo M; Lester RD; Montel V; Eastman B; Takimoto S; Gonias SL
    J Biol Chem; 2009 Aug; 284(34):22825-33. PubMed ID: 19546228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human breast cancer xenograft growth by cruciferous vegetable constituent benzyl isothiocyanate.
    Warin R; Xiao D; Arlotti JA; Bommareddy A; Singh SV
    Mol Carcinog; 2010 May; 49(5):500-7. PubMed ID: 20422714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.
    Kim SH; Nagalingam A; Saxena NK; Singh SV; Sharma D
    Carcinogenesis; 2011 Mar; 32(3):359-67. PubMed ID: 21163886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
    Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
    Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
    Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.
    Kim SH; Singh SV
    Breast Cancer Res Treat; 2015 Feb; 149(3):681-92. PubMed ID: 25663545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
    Lee J; Hahm ER; Marcus AI; Singh SV
    Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
    Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.